HRES 484 · 117th Congress
Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.
This bill hasn't been enriched yet — fetch cosponsors, actions, subjects, titles, and summaries from Congress.gov.
Why?
Every bill carries a core record (title, sponsor, latest action) that Concord fetches up front. The detailed sections — cosponsors, action history, subjects, titles, and summaries — live behind separate Congress.gov endpoints, so they're fetched on demand rather than for all 50,000+ bills at once. Until a bill has been enriched, those sections stay empty.
Brief
Executive summary
AI-generated
No executive summary yet — generate one to distill the facts below into a few sentences.
- Sponsor
- Mariannette Miller-Meeks
- Policy area
- Commerce
- Introduced
- 2021-06-17
- Chamber
- House
Status
2022-11-01 —
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Coalition
0 cosponsors
(0 original)
0 actions on file
0 recorded votes
No CRS summary available for this bill.
Latest action
2022-11-01 — Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Summaries
Summaries not yet fetched.
Sponsor
Mariannette Miller-MeeksCosponsors
Cosponsors not yet fetched.
Vote history
No votes recorded for this bill yet.
Action history
Action history not yet fetched.
Subjects
Subjects not yet fetched.
Titles
Titles not yet fetched.